Replimune Group, Inc.
REPL
$11.20
+107.02%
REPL price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Replimune Group, Inc.'s 12-month outlook, with a consensus price target around $10.67 and implied upside of -4.8% versus the current price.
Average Target
$10.67
0 analysts
Implied Upside
-4.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$2 - $17
Analyst target range
REPL Technical Analysis
Beta
0.87
0.87x market volatility
Max Drawdown
-86.5%
Largest decline past year
52-Week Range
$2-$13
Price range past year
Annual Return
+59.3%
Cumulative gain past year
| Period | REPL Return | S&P 500 |
|---|---|---|
| 1m | -0.2% | +0.2% |
| 3m | +348.0% | +3.7% |
| 6m | +59.3% | +8.0% |
| 1y | +59.3% | +18.2% |
| ytd | +25.8% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is REPL Overvalued?
PE
-2.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-2.0x
Enterprise Value Multiple